NDC 49702-202

COMBIVIR

Lamivudine And Zidovudine

COMBIVIR is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Lamivudine; Zidovudine.

Product ID49702-202_1e824e5f-a76c-4d23-8672-fa78d4613d10
NDC49702-202
Product TypeHuman Prescription Drug
Proprietary NameCOMBIVIR
Generic NameLamivudine And Zidovudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2010-10-19
Marketing CategoryNDA / NDA
Application NumberNDA020857
Labeler NameViiV Healthcare Company
Substance NameLAMIVUDINE; ZIDOVUDINE
Active Ingredient Strength150 mg/1; mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 49702-202-18

60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18)
Marketing Start Date2010-10-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49702-202-29 [49702020229]

COMBIVIR TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020857
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-10-19
Marketing End Date2018-02-28

NDC 49702-202-18 [49702020218]

COMBIVIR TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020857
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-10-19

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE150 mg/1

OpenFDA Data

SPL SET ID:16da660b-9981-4d24-a14a-94c7744fce4f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200082
  • 213088
    • UPC Code
  • 0349702202184

    • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    Medicade Reported Pricing

    49702020229 COMBIVIR TABLET

    Pricing Unit: EA | Drug Type:

    49702020218 COMBIVIR TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "COMBIVIR" or generic name "Lamivudine And Zidovudine"

    NDCBrand NameGeneric Name
    21695-846COMBIVIRlamivudine and zidovudine
    49702-202COMBIVIRlamivudine and zidovudine
    50090-0610COMBIVIRlamivudine and zidovudine
    52959-546COMBIVIRlamivudine and zidovudine
    53808-0895COMBIVIRlamivudine and zidovudine
    21695-996Lamivudine and ZidovudineLamivudine and Zidovudine
    31722-506LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    31722-739Lamivudine and ZidovudineLamivudine and Zidovudine
    33342-003Lamivudine and ZidovudineLamivudine and Zidovudine
    42291-363Lamivudine and ZidovudineLamivudine and Zidovudine
    43063-346Lamivudine and ZidovudineLamivudine and Zidovudine
    43063-900lamiVUDine and ZIDOVUDINElamiVUDine and ZIDOVUDINE
    50090-3920LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    50268-456LAMIVUDINE and ZIDOVUDINELAMIVUDINE and ZIDOVUDINE
    50436-0597Lamivudine and ZidovudineLamivudine and Zidovudine
    54741-102Lamivudine and Zidovudinelamivudine and zidovudine
    55700-096Lamivudine and ZidovudineLamivudine and Zidovudine
    57297-284LAMIVUDINE AND ZIDOVUDINELAMIVUDINE AND ZIDOVUDINE
    63629-4872Lamivudine and ZidovudineLamivudine and Zidovudine
    64380-707Lamivudine and ZidovudineLamivudine and Zidovudine
    65862-036Lamivudine and ZidovudineLamivudine and Zidovudine
    65862-597Lamivudine and ZidovudineLamivudine and Zidovudine

    Trademark Results [COMBIVIR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    COMBIVIR
    COMBIVIR
    75244811 2158546 Live/Registered
    VIIV HEALTHCARE COMPANY
    1997-02-20
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.